-
ISSCR Founder Leonard Zon talks about the development and growth of the ISSCR and
Leonard Zon
ISSCR Founder
-
Understanding the Clinical Applications of MSCs
Megan Munsie, PhD, University of Melbourne and Mark Young, MBBS, FACSEP, University of Queensland
-
'Know Thy Cell' - Rigorous Assays for the Characterization of MSCs
Moustapha Kassem, MD, PhD, University Hospital of Odense
-
Tissue Specific Stem / Progenitor Cells Known as MSCS
Pamela Robey, PhD, National Institutes of Health
-
Cell Therapy Regulations in the U.S.
Joyce Frey-Vansconcells, PhD, Frey-Vasconcells Consultants LLC and Lei Xu, MD, PhD, U.S. FDA
-
Japan's Regulatory Framework for Expedited Clinical Application of Cell-Based Therapeutic Products
Yoji Sato, PhD, National Institutes of Health Sciences (Japan)
-
Using Imaging Technologies to Understand Mechanism of Action, Safety and Efficacy of Cellular Therapies
Bill Shingleton, PhD, GE Healthcare and Greg Mullen, PhD, King's College London
-
Developing Standards for Cell Therapy and Regenerative Medicine
Judith Arcidiacono, MS, U.S. FDA and Sheng Lin-Gibson, PhD, National Institute of Standards and Technology (U.S.)
-
Cell Therapy Process Development and Process Changes
Ian Harris, PhD, Janssen Research and Development, LLC and Thomas Finn, PhD, U.S. FDA
-
Preclinical Development for Cell Therapy Products
Jane Lebkowski, PhD, Asterias Therapeutics and Iwen Wu, PhD, U.S. FDA